Serum HLA class I antigen levels in allogeneic bone marrow transplantation: A possible marker of acute GVHD

Bone Marrow Transplantation

Volumn 17, Issue 5, 1996, Pages 753-758

  Puppo, F ^a,d   Brenci, S ^a   Ghio, M ^a   Bignardi, D ^a   Contini, P ^a   Bacigalupo, A ^b   Van Lint, M T ^b   Scudeletti, M ^a   Ferrone, S ^c   Indiveri, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d DIMI   (Italy)

Author keywords

BMT; GVHD; HLA; MHC

Indexed keywords

BIOLOGICAL MARKER; HLA ANTIGEN CLASS 1;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYREXIA IDIOPATHICA; SCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INFECTION; LEUKEMIA; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 15844375483     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Natali PG, Bigotti A, Nicotra MR et al. Distribution of human class I (HLA-A. B, C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 1984; 44: 4679-4687.
2. Van Rood JJ, van Leeuwen A, van Santen MCT. Anti HL-A2 inhibitor in normal human serum. Nature 1970; 226: 366-367.
3. Charlton RK, Zmijewski CM, Soluble HL-A7 antigen: localization in the β-lipoprotein fraction of human serum. Science 1970; 170: 636-637.
4. Pellegrino MA, Ferrone S, Pellegrino AG et al. Evaluation of two sources of soluble HL-A antigens: platelets and serum. Eur J Immunol 1974; 4: 246-250.
5. Ferrone S, Pellegrino MA, Billing R et al. Production of antiW24 xenoantisera in rabbits. Tissue Antigens 1975; 5: 41-47.
6. Pellegrino MA, Indiveri F, Fagiolo U et al. Immunogenicity of serum HLA antigens in allogeneic combinations. Transplantation 1982; 33: 530-533.
7. Krensky AM, Weiss A, Crabtree G et al. T lymphocyte-antigen interactions in transplant rejection. New Engl J Med 1990; 322: 510-517.
8. Puppo F, Brenci S, Lanza L et al. Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum Immunol 1994; 40: 259-266.
9. Saririan K, Wali A, Almeida RP, Russo C. Increased serum HLA class I molecule levels in elderly human responders to influenza vaccination. Tissue Antigens 1993; 42: 9-13.
10. Davies HffS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524-527.
11. Pollard SG, Davies HffS, Calne RY. Peroperative appearance of serum class I antigen during liver transplantation. Transplantation 1990; 49: 659-660.
12. Tilg H, Westhoff U, Vogel W et al. Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol 1992; 14: 417-419.
13. Rhynes VK, McDonald JC, Gelder FB et al. Soluble HLA class I in the serum of transplant recipients. Ann Surg 1993; 217: 485-491.
14. Puppo F, Pellicci R, Brenci S et al. HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection. Hum Immunol 1994; 40: 166-170.
15. Zavazava N, Böttcher H, Müller-Ruchholz W. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993; 42: 20-26.
16. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW et al. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 1994; 40: 191-201.
17. Westhoff U, Doxiadis I, Beelen DW et al. Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation 1989; 48: 890-893.
18. Van Lint MT, Bacigalupo A, Frassoni F et al. Bone marrow transplantation (BMT) for acute lymphoblastic leukemia (ALL) in remission. Haematologica 1986; 71: 135-138.
19. Bacigalupo A, Van Lint MT, Occhini D et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood 1991; 77: 1423-1428.
20. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843.
21. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
22. Schwaighofer H, Herold M, Schwarz T et al. Serum levels of interleukin-6, interleukin-8, and C-reactive protein after human allogeneic bone marrow transplantation. Transplantation 1994; 58: 430-436.
23. Bamstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes. HLA and other human cell surface antigens: new tools for genetic analysis. Cell 1978; 14: 9-20.
24. Comuzio S, Puppo F, Ruzzenenti R et al. Simple ELISA method for the evaluation of soluble HLA class I antigens in human serum. J Clin Lab Anal 1991; 5: 278-283.
25. Ferreira A, Revilla Y, Bootello A, Gonzalez-Porqué P. Use of the ELISA to detect and quantify histocompatibility antigens and their subunits. J Immunol Meth 1983; 65: 373-381.
26. Ferrara JLM, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
27. Vogelsang G, Hess AD. Graft-versus-host-disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
28. Brieva JA, Villar LM, Leoro G et al. Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Clin Exp Immunol 1990; 82: 390-395.
29. Villar LM, Roy G, Lazaro I et al. Detection of soluble class I molecules (non-HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture. Eur J Immunol 1989; 19: 1835-1839.
30. Russo C, Fotino M, Carbonara A, Ferrone S. A double determinant immunoassay for HLA class I typing using serum as an antigen source. Hum Immunol 1987, 19: 69-77.